2006
DOI: 10.1080/09546630500424805
|View full text |Cite
|
Sign up to set email alerts
|

Dermatomyositis‐like eruption with long‐term hydroxyurea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
2
0
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 2 publications
0
2
0
1
Order By: Relevance
“…However, the cost implications, unavailability of necessary expertise, and the problems of finding suitable donor constitute a major setback to this approach in developing countries [5]. In clinical practice, blood transfusion, Hydroxyurea, Hydroxycarbamide, Clotrimazole, and erythropoietin are used in SCD management, but the side effects of these drugs such as iron overload and mutagenic and teratogenic assertions limit their clinical use [6, 7]. …”
Section: Introductionmentioning
confidence: 99%
“…However, the cost implications, unavailability of necessary expertise, and the problems of finding suitable donor constitute a major setback to this approach in developing countries [5]. In clinical practice, blood transfusion, Hydroxyurea, Hydroxycarbamide, Clotrimazole, and erythropoietin are used in SCD management, but the side effects of these drugs such as iron overload and mutagenic and teratogenic assertions limit their clinical use [6, 7]. …”
Section: Introductionmentioning
confidence: 99%
“…Deux pourcent de la population en République Démocratique du Congo (RDC) sont touchés par cette maladie, soit plus d'un million d'habitants (Mpiana et al, 2007a). Près de 80% d'enfants atteints par cette anémie meurent avant leur cinquième anniversaire s'ils ne sont pas suivis médicalement (Stryer et al, 1997;Voet et Voet, 1998) Plusieurs modes de traitements ont été envisagés en vue de soulager les malades, entre autre le greffage de la moelle osseuse, la thérapie génétique, les transfusions sanguines répétées, la prise de l'hydroxyurée etc., Mais il s'avère que ces traitements sont non seulement inefficaces et très coûteux pour les populations pauvres d'Afrique, mais peuvent constituer également un risque d'infection au VIH/SIDA (Sofowora, 1998;Wajcman, 2003;Eliot et al, 2006).…”
Section: Introductionunclassified
“…These treatments are inaccessible to African populations because they are very expensive. They can also pose a risk of transmitting diseases such as hepatitis and HIV/AIDS [7][8][9]. In Niger, the population has acquired several years of experience with the traditional treatment of illnesses using plants, as reported by [10] in an ethnobotanical survey of traditional health practitioners in the Tillabery and Niamey regions.…”
Section: Introductionmentioning
confidence: 99%